Both in Pharmaceuticals
Traws Pharma vs Apimeds Pharmaceuticals US
Over the past year TRAW returned −88.8% and APUS returned −85.2%; their daily moves had a correlation of -0.00.
TRAW −88.8% APUS −85.2%Growth of $1, one year, split-adjusted
| Metric | TRAW | APUS |
|---|---|---|
| Price | $0.2960 | $3.01 |
| Market cap | $4.5M | $4.5M |
| Today | −1.66% | −6.23% |
| 1 month | −45.7% | −26.6% |
| 6 months | −80.1% | — |
| Year to date | −73.8% | −81.6% |
| 1 year | −89.4% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | -$8.6M |
| Dividend yield | — | — |
| Volatility (60d) | 79.3% | 265.1% |
| Short % of float | 5.2% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).